TY - JOUR
T1 - Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection
AU - Huynh, Jeremy P.
AU - Lin, Chih Chung
AU - Kimmey, Jacqueline M.
AU - Jarjour, Nicholas N.
AU - Schwarzkopf, Elizabeth A.
AU - Bradstreet, Tara R.
AU - Shchukina, Irina
AU - Shpynov, Oleg
AU - Weaver, Casey T.
AU - Taneja, Reshma
AU - Artyomov, Maxim N.
AU - Edelson, Brian T.
AU - Stallings, Christina L.
N1 - Funding Information:
C.L. Stallings is supported by an Arnold and Mabel Beckman Foundation Beckman Young Investigator Award and a Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease award. B.T. Edelson was supported by National Institutes of Health grant R01 AI113118 and a Burroughs Wellcome Fund Career Award for Medical Scientists. J.P. Huynh was supported by a National Science Foundation Graduate Research Fellowship (DGE-1143954). C.-C. Lin was supported by the McDonnell International Scholars Academy at Washington University in St. Louis. J.M. Kimmey was supported by a National Science Foundation Graduate Research Fellowship (DGE-1143954) and the National Institute of Medical General Sciences Cell and Molecular Biology Training grant GM007067. N.N. Jarjour was supported by National Institutes of Health grant 5T32AI007163. The Bhlhe40GFP mouse strain used, STOCK Tg(Bhlhe40-EGFP) PX84Gsat/Mmucd, identification number 034730-UCD, was obtained from the Mutant Mouse Regional Resource Center, a National Center for Research Resources–National Institutes of Health–funded strain repository, and was donated to the Mutant Mouse Regional Resource Center by the National Institute of Neurological Disorders and Stroke–funded Gene Expression Nervous System Atlas BAC transgenic project (The GENSAT Project; National Institute of Neurological Disorders and Stroke contract N01NS02331 to the Rockefeller University). Research reported in this publication was supported by the Washington University in St. Louis Institute of Clinical and Translational Sciences grant from the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1 TR000448).
Funding Information:
C.L. Stallings is supported by an Arnold and Mabel Beckman Foundation Beckman Young Investigator Award and a Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease award. B.T. Edelson was supported by National Institutes of Health grant R01 AI113118 and a Burroughs Wellcome Fund Career Award for Medical Scientists. J.P. Huynh was supported by a National Science Foundation Graduate Research Fellowship (DGE-1143954). C.-C. Lin was supported by the McDon-nell International Scholars Academy at Washington University in St. Louis. J.M. Kimmey was supported by a National Science Foundation Graduate Research Fellowship (DGE-1143954) and the National Institute of Medical General Sciences Cell and Molecular Biology Training grant GM007067. N.N. Jarjour was supported by National Institutes of Health grant 5T32AI007163. The Bhlhe40GFP mouse strain used, STOCK Tg(Bhlhe40-EGFP) PX84Gsat?Mmucd, identification number 034730-UCD, was obtained from the Mutant Mouse Regional Resource Center, a National Center for Research Resources–National Institutes of Health–funded strain repository, and was donated to the Mutant Mouse Regional Resource Center by the National Institute of Neurological Disorders and Stroke–funded Gene Expression Nervous System Atlas BAC transgenic project (The GENSAT Project; National Institute of Neurological Disorders and Stroke contract N01NS02331 to the Rockefeller University). Research reported in this publication was supported by the Washington University in St. Louis Institute of Clinical and Translational Sciences grant from the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1 TR000448). The authors declare no competing financial interests.
Publisher Copyright:
© 2018 Huynh et al.
PY - 2018/7/1
Y1 - 2018/7/1
N2 - The cytokine IL-10 antagonizes pathways that control Mycobacterium tuberculosis (Mtb) infection. Nevertheless, the impact of IL-10 during Mtb infection has been difficult to decipher because loss-of-function studies in animal models have yielded only mild phenotypes. We have discovered that the transcription factor basic helix-loop-helix family member e40 (Bhlhe40) is required to repress Il10 expression during Mtb infection. Loss of Bhlhe40 in mice results in higher Il10 expression, higher bacterial burden, and early susceptibility similar to that observed in mice lacking IFN-γ. Deletion of Il10 in Bhlhe40−/− mice reverses these phenotypes. Bhlhe40 deletion in T cells or CD11c+ cells is sufficient to cause susceptibility to Mtb. Bhlhe40 represents the first transcription factor found to be essential during Mtb infection to specifically regulate Il10 expression, revealing the importance of strict control of IL-10 production by innate and adaptive immune cells during infection. Our findings uncover a previously elusive but significant role for IL-10 in Mtb pathogenesis.
AB - The cytokine IL-10 antagonizes pathways that control Mycobacterium tuberculosis (Mtb) infection. Nevertheless, the impact of IL-10 during Mtb infection has been difficult to decipher because loss-of-function studies in animal models have yielded only mild phenotypes. We have discovered that the transcription factor basic helix-loop-helix family member e40 (Bhlhe40) is required to repress Il10 expression during Mtb infection. Loss of Bhlhe40 in mice results in higher Il10 expression, higher bacterial burden, and early susceptibility similar to that observed in mice lacking IFN-γ. Deletion of Il10 in Bhlhe40−/− mice reverses these phenotypes. Bhlhe40 deletion in T cells or CD11c+ cells is sufficient to cause susceptibility to Mtb. Bhlhe40 represents the first transcription factor found to be essential during Mtb infection to specifically regulate Il10 expression, revealing the importance of strict control of IL-10 production by innate and adaptive immune cells during infection. Our findings uncover a previously elusive but significant role for IL-10 in Mtb pathogenesis.
UR - http://www.scopus.com/inward/record.url?scp=85054630864&partnerID=8YFLogxK
U2 - 10.1084/jem.20171704
DO - 10.1084/jem.20171704
M3 - Article
C2 - 29773644
AN - SCOPUS:85054630864
SN - 0022-1007
VL - 215
SP - 1823
EP - 1838
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 7
ER -